Cargando…
Genomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma
Epithelial responses to the cytokine interleukin-13 (IL-13) cause airway obstruction in asthma. Here we utilized multiple genomic techniques to identify IL-13-responsive regulatory elements in bronchial epithelial cells and used these data to develop a CRISPR interference (CRISPRi)-based therapeutic...
Autores principales: | Koh, Kyung Duk, Bonser, Luke R., Eckalbar, Walter L., Yizhar-Barnea, Ofer, Shen, Jiangshan, Zeng, Xiaoning, Hargett, Kirsten L., Sun, Dingyuan I., Zlock, Lorna T., Finkbeiner, Walter E., Ahituv, Nadav, Erle, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903679/ https://www.ncbi.nlm.nih.gov/pubmed/36777184 http://dx.doi.org/10.1016/j.xgen.2022.100229 |
Ejemplares similares
-
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
por: Bonser, Luke R., et al.
Publicado: (2021) -
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
por: Bonser, Luke R., et al.
Publicado: (2022) -
Epithelial miR-141 regulates IL-13–induced airway mucus production
por: Siddiqui, Sana, et al.
Publicado: (2021) -
Absent from DNA and protein: genomic characterization of nullomers and nullpeptides across functional categories and evolution
por: Georgakopoulos-Soares, Ilias, et al.
Publicado: (2021) -
Cultures of human tracheal gland cells of mucous or serous phenotype
por: Finkbeiner, Walter E., et al.
Publicado: (2009)